PharmaTher Announces Notice of Allowance for US Patent Covering Ketamine for the Potential Treatment of Parkinson’s Disease and Motor Disorders

PharmaTher Holdings Ltd. announced that the United States Patent and Trademark Office has provided a Notice of Allowance for patent application No. 15/574,346, which includes claims intended to cover ketamine in the potential treatment of Parkinson’s Disease and motor disorders.